- Report
- February 2024
- 202 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 213 Pages
Global
From €5313EUR$5,500USD£4,543GBP
- Report
- March 2024
- 183 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 194 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 194 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 181 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 199 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- March 2024
- 197 Pages
Global
From €3259EUR$3,374USD£2,787GBP
€3621EUR$3,749USD£3,097GBP
- Report
- June 2023
- 364 Pages
Global
From €4781EUR$5,123USD£3,950GBP
- Report
- May 2023
- 375 Pages
Global
From €4781EUR$5,123USD£3,950GBP
- Report
- April 2024
- 402 Pages
Global
From €4782EUR$4,950USD£4,089GBP
- Report
- March 2024
- 133 Pages
Global
From €5747EUR$5,950USD£4,915GBP
- Report
- July 2023
- 180 Pages
Global
From €5747EUR$5,950USD£4,915GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- February 2024
- 200 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 175 Pages
Global
From €4830EUR$5,000USD£4,130GBP
- Report
- January 2024
- 200 Pages
Global
From €4830EUR$5,000USD£4,130GBP
Toxoid vaccines are a type of vaccine that use a modified form of a toxin or toxin-producing microorganism to stimulate the body's immune system to produce antibodies against the toxin. The toxin is usually inactivated or weakened so that it does not cause disease, but still stimulates the body's immune system to produce antibodies. Toxoid vaccines are used to protect against a variety of diseases, including diphtheria, tetanus, and pertussis.
Toxoid vaccines are widely used in both developed and developing countries, and are an important part of routine immunization programs. They are also used in the prevention of certain occupational diseases, such as tetanus in healthcare workers.
The toxoid vaccine market is highly competitive, with a number of companies offering a range of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more